Min et al. reported odds ratios of 0.81 (CI: 0.44 to 1.49) for acute kidney injury and 1.71 (CI: 0.57 to 5.17) for hypoglycaemia as compared to GLP-1 receptor agonists/Dipeptidyl Peptidase 4 inhibitors (Figure 7b,c). Here, GLP1R is linked to Hypoglycemia.